STOCK TITAN

Shareholders at Acadia Healthcare (NASDAQ: ACHC) approve directors, pay and plans

(Moderate)
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Acadia Healthcare Company, Inc. held its annual meeting of stockholders on May 6, 2026. Stockholders elected three Class III directors—Daniel J. Cancelmi, Michael J. Fucci and Patrice A. Harris, M.D., M.A.—each receiving over 73.5 million votes in favor.

Investors also approved a second amendment to the Amended and Restated Incentive Compensation Plan, with 80,102,444 votes for and 779,641 against. On a non-binding advisory basis, stockholders approved compensation of the Named Executive Officers, with 60,889,503 votes for and 19,942,924 against.

Finally, stockholders ratified Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 83,941,435 votes for and 1,947,371 against.

Positive

  • None.

Negative

  • None.
Item 5.07 Submission of Matters to a Vote of Security Holders Governance
Results of a shareholder vote on proposals at an annual or special meeting.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, and exhibit attachments filed with this report.
Votes for Cancelmi 80,276,613 votes Election of Daniel J. Cancelmi as Class III director
Votes for Fucci 73,587,992 votes Election of Michael J. Fucci as Class III director
Votes for Harris 80,535,426 votes Election of Patrice A. Harris, M.D., M.A. as Class III director
Incentive plan amendment approval 80,102,444 votes for Second amendment to Amended and Restated Incentive Compensation Plan
Say-on-pay approval 60,889,503 votes for Non-binding advisory vote on Named Executive Officer compensation
Auditor ratification votes for 83,941,435 votes for Ratification of Ernst & Young LLP for fiscal year ending December 31, 2026
Class III directors financial
"were elected to serve as Class III directors until the Company’s annual meeting"
Class III directors are members of a company’s board assigned to one of several staggered term groups, so only that class faces election in a particular year while other classes stay in place. For investors this affects corporate control and takeover risk because staggered elections make it slower and harder for an outside group to replace a majority of directors quickly—think of it as a rotating schedule for board seats that provides continuity but can also entrench existing leadership.
Incentive Compensation Plan financial
"approved a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
non-binding advisory basis financial
"approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers"
A non-binding advisory basis is guidance or a recommendation offered for informational purposes that does not create legal obligations or guarantees; recipients can accept, modify, or ignore it without contractual consequences. Investors should treat it like a weather forecast for planning—useful for forming expectations and assessing risk, but not a firm promise—so they should verify assumptions, seek confirming information, and avoid relying on it as the sole basis for investment decisions.
Named Executive Officers financial
"the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement"
Named executive officers are the senior company leaders whose names, roles and compensation are singled out in required regulatory filings; this typically includes the chief executive, chief financial officer and the next highest‑paid senior officers. Investors treat this list like a team roster — it shows who makes key decisions, how they are paid and whether incentives align with shareholder interests, so changes or pay patterns can signal governance quality, risk or strategic shifts.
independent registered public accounting firm financial
"ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm"
An independent registered public accounting firm is an outside accounting company officially registered with the government regulator to examine and report on a public company's financial records and controls. Investors treat its reports like an impartial inspector’s certificate — they add credibility to financial statements, help spot errors or misleading claims, and reduce the risk that shareholders are relying on unchecked or biased numbers.
broker non-votes financial
"Abstain | Broker Non-Votes 80,102,444 | 779,641 | 53,750 | 5,002,484"
Broker non-votes occur when a brokerage firm is unable to vote on a shareholder’s behalf during a company election or decision because the shareholder has not given specific voting instructions, and the broker is not allowed or chooses not to vote on certain matters. They are important because they can affect the outcome of votes, especially when the results are close, by effectively reducing the total number of votes cast.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Acadia Healthcare (ACHC) stockholders decide at the 2026 annual meeting?

Acadia Healthcare stockholders elected three Class III directors, approved an amendment to the incentive compensation plan, endorsed executive pay on an advisory basis, and ratified Ernst & Young LLP as independent auditor for 2026, confirming the company’s existing leadership, compensation framework, and audit relationship.

Which directors were elected at Acadia Healthcare (ACHC)’s 2026 annual meeting?

Stockholders elected Daniel J. Cancelmi, Michael J. Fucci, and Patrice A. Harris, M.D., M.A. as Class III directors. They will serve until the 2029 annual meeting, or until their successors are elected and take office, providing continuity on Acadia Healthcare’s board of directors for the next several years.

How did Acadia Healthcare (ACHC) investors vote on the incentive compensation plan amendment?

Investors approved a second amendment to Acadia Healthcare’s Amended and Restated Incentive Compensation Plan with 80,102,444 votes for, 779,641 against, and 53,750 abstentions, plus 5,002,484 broker non-votes. This approval maintains and updates the company’s equity and incentive compensation structure for eligible participants.

What were the results of Acadia Healthcare (ACHC)’s say-on-pay vote for named executives?

On a non-binding advisory basis, Acadia Healthcare stockholders approved compensation for the Named Executive Officers, with 60,889,503 votes for, 19,942,924 against, and 103,408 abstentions, along with 5,002,484 broker non-votes. This vote indicates investor support for the company’s disclosed executive pay practices.

Who is Acadia Healthcare (ACHC)’s independent auditor for the year ending December 31, 2026?

Stockholders ratified Ernst & Young LLP as Acadia Healthcare’s independent registered public accounting firm for the fiscal year ending December 31, 2026, with 83,941,435 votes in favor, 1,947,371 against, and 49,513 abstentions, confirming continuation of the company’s existing external audit relationship.

What business does Acadia Healthcare (ACHC) operate in the U.S. and Puerto Rico?

Acadia Healthcare is a holding company whose subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers, and outpatient behavioral healthcare facilities across the United States and Puerto Rico, serving diverse behavioral health and recovery needs.
false 0001520697 0001520697 2026-05-06 2026-05-06
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): May 6, 2026

 

 

Acadia Healthcare Company, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

 

 

Delaware   001-35331   45-2492228
(State or Other Jurisdiction
of Incorporation)
 

(Commission

File Number)

  (IRS Employer
Identification No.)

 

4020 Aspen Grove Drive, Suite 900

Franklin, Tennessee

  37067
(Address of Principal Executive Offices)   (Zip Code)

(615) 861-6000

(Registrant’s Telephone Number, including Area Code)

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (See General Instruction A.2. below):

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol

 

Name of each exchange
on which registered

Common Stock, $0.01 par value   ACHC   NASDAQ Global Select Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 5.07 Submission of Matters to a Vote of Security Holders

Acadia Healthcare Company, Inc. (the “Company”) held its annual meeting of stockholders on May 6, 2026 (the “Annual Meeting”). The proposals considered at the Annual Meeting were voted on as follows:

1.  The individuals listed below were elected to serve as Class III directors until the Company’s annual meeting of stockholders in 2029 or until their successors have been elected and take office. The voting results were as follows:

 

     For      Against      Abstain      Broker Non-Votes  

Daniel J. Cancelmi

     80,276,613        608,441        50,781        5,002,484  

Michael J. Fucci

     73,587,992        7,296,976        50,867        5,002,484  

Patrice A. Harris, M.D., M.A.

     80,535,426        350,255        50,154        5,002,484  

2. The Company’s stockholders approved a second amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, by the following vote:

 

For

  

Against

  

Abstain

  

Broker Non-Votes

80,102,444    779,641    53,750    5,002,484

3.  The Company’s stockholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers (as defined in the Company’s definitive proxy statement filed with the SEC on March 25, 2026), by the following vote:

 

For

  

Against

  

Abstain

  

Broker Non-Votes

60,889,503    19,942,924    103,408    5,002,484

4. The Company’s stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026, by the following vote:

 

For

  

Against

  

Abstain

83,941,435    1,947,371    49,513

Description of Business

Unless the context otherwise requires, all references herein to “Acadia,” “the Company,” “we,” “us” or “our” mean Acadia Healthcare Company, Inc. and its consolidated subsidiaries. Acadia Healthcare Company, Inc. is a holding company whose direct and indirect subsidiaries own and operate acute inpatient psychiatric facilities, specialty treatment facilities, comprehensive treatment centers, residential treatment centers and facilities providing outpatient behavioral healthcare services to serve the behavioral healthcare and recovery needs of communities throughout the U.S. and Puerto Rico.

 


Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

The following exhibits are filed herewith:

 

Exhibit No.

  

Description

10.1    Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan, as amended (a)
10.2    Second Amendment to the Acadia Healthcare Company, Inc. Amended and Restated Incentive Compensation Plan (b)
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).
 
(a)

Incorporated by reference to Appendix B to the Company’s Definitive Proxy Statement filed with the SEC on March 25, 2026 (File No. 001-35331).

(b)

Incorporated by reference to Appendix A to the Company’s Definitive Proxy Statement filed with the SEC on March 25, 2026 (File No. 001-35331).

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date: May 6, 2026     ACADIA HEALTHCARE COMPANY, INC.
    By:  

/s/ Brian P. Farley

      Brian P. Farley
      Executive Vice President, Chief Legal and Administrative Officer, and Secretary

Filing Exhibits & Attachments

3 documents